首页|新型冠状病毒S1、S2和NTD抗原特异性B细胞及其亚型标记技术的建立与应用

新型冠状病毒S1、S2和NTD抗原特异性B细胞及其亚型标记技术的建立与应用

扫码查看
建立一种新型冠状病毒(Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2)S1、S2、NTD蛋白特异性B细胞及其亚型的标记技术,该技术可通过与流式细胞术联用检测抗原特异性B细胞及其亚型含量,或与10 ×免疫组库联用对抗原特异性B细胞进行测序.首先,测试最佳蛋白使用浓度:将生物素标记的S1、S2和NTD蛋白按照600 nmol/L、1 200 nmol/L、2400 nmol/L、3600 nmol/L和4 800 nmol/L分别与荧光素-亲和素偶联,通过流式检测S1+CD19+B、S2+CD19+B、NTD+CD19+B细胞占比,确定不同蛋白对应的最佳使用浓度;进一步优化生物素-蛋白与荧光素-亲和素的比例:将检测生物素-蛋白与荧光-亲和素的摩尔比分别按照4∶1,5∶1和6∶1比例测试,对小鼠脾脏 S1+CD19+B、S2+CD19+B、NTD+CD19+B 细胞及 S1+CD19+CD27+B、S2+CD19+CD27+B、NTD+CD19+CD27+B细胞的检测效果,优化荧光素-亲和素的最佳使用量;通过测试BV421、Super Bright 600、PE、PE/Cy7和APC等荧光对小鼠脾细胞的非特异结合能力,选择非特异结合较弱的荧光;根据筛选的荧光,给生物素化的S1、S2和NTD均标记PE和APC荧光,建立检测这3个蛋白特异性B细胞和记忆B细胞的方法,并测试带核酸序列的荧光素-亲和素对B细胞和记忆B细胞的检测效果,测试该方法的稳定性.S1、S2和NTD蛋白浓度分别为4800 nmol/L、3 600 nmol/L和3 600 nmol/L时,对B细胞的检测效果最佳,且对阴性小鼠的染色效果较低;生物素-S1蛋白与荧光素-亲和素的最佳摩尔比为6∶1时,检测结果最佳;生物素-S2蛋白、生物素-NTD蛋白与荧光素-亲和素均在4∶1时,检测结果最佳,且在该浓度下BV421、APC、Super Bright 600、PE与细胞的非特异结合较弱;建立了一种检测SARS-CoV-2 S1、S2和NTD抗原特异性B细胞及记忆B细胞的方法,通过对一批样本的重复3次检测,发现该方法较为稳定,CV值≤ 20%.通过抗原特异性B细胞标记技术,实现了对SARS-CoV-2 S1、S2和NTD蛋白特异性B细胞及其亚型标记技术方法,并且具有良好的适用性,可用于与流式细胞术检测抗原特异性B细胞及记忆B细胞和10 ×免疫组库测序联合使用.
Establishment and Application of A Labeling Method for S1-,S2-,and NTD Antigen-specific B Cells and Their Subtypes of SARS-CoV-2
To establish a labeling method for spike(S)1-,S2-,and N-terminal domain(NTD)-specific B cells(and their subtypes)of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2).This method could be used with flow cytometry to test,or in 10 × immune repertoire sequence to obtain the sequence of antigen-specific B cells and their subtypes.First,S1,S2,and NTD proteins were coupled with fluorescein-streptavidin(600,1200,2400,3600 and 4800 nmol/L),respectively.Antigen-specific B cells were detected by flow cytometry to determine the optimal concentration.Second,the molar ratio of biotin-protein and fluorescein-streptavidin was tested at ratios of 4∶1,5∶1,and 6∶1,respectively.According to the ratio of S1+cluster of differentiation(CD)19+B cells,S2+CD19+B cells,NTD+CD19+B cells,as well as S1+CD19+CD27+B cells,S2+CD19+CD27+B cells,and NTD+CD19+CD27+B cells,the optimal concentration was obtained.Third,the non-specific effects of different types of fluorescein(BV421,Super Bright 600,PE,PE/Cy7 and APC)were tested to evaluate their non-specific binding.Fourth,the established method was repeated thrice to test its stability in flow cytometry.We also tested it with fluorescein-avidin-biotin-containing nucleotide sequences which could be used in a 10 × immune repertoire sequence.First,the optimal concentrations(in nmol/L)of S1,S2,and NTD proteins were 4800,3600,and 3600 nmol/L,respectively.Second,the optimal molar ratio of biotin-S1 protein to fluorescein-avidin was 6∶1,whereas the most suitable molar ratio of biotin-S2 protein and biotin-NTD protein to fluorescein-avidin was 4∶1,respectively.At this concentration,BV421,APC,Super Bright 600,and PE showed weak non-specific binding.Third,repeating this method thrice showed it to be highly stable,with a coefficient of variation of≤20%,and it was suitable for fluorescein-avidin-biotin-containing nucleotide sequences.The established labeling technology for S1-,S2-,and NTD protein-specific B cells(and their subtypes)of SARS-CoV-2 was relatively stable,and could be used in conjunction with flow cytometry and 10 × immune repertoire sequencing.

Flow cytometryBiotin-antigenFluorescein-avidinSARS-CoV-2Antigen-specific B cells

宋彦丽、杨惠洁、赵玉秀、鲍春婷、李淑艳、李长贵

展开 >

武汉生物制品研究所有限责任公司病毒性疫苗研究二室,武汉 430207

中国食品药品检定研究院呼吸道病毒疫苗室,北京 102600

北京生物制品研究所课题一组,北京 100176

长春生物制品研究所有限责任公司疫苗研究室,长春 130012

展开 >

流式细胞术 生物素-蛋白 荧光素-亲和素 新型冠状病毒 抗原特异性B细胞

2024

病毒学报
中国微生物学会

病毒学报

CSTPCD北大核心
影响因子:1.046
ISSN:1000-8721
年,卷(期):2024.40(4)